Omalizumab May Be Effective, Safe for RDEB With High IgE Levels

Omalizumab May Be Effective, Safe for RDEB With High IgE Levels

311867

Omalizumab May Be Effective, Safe for RDEB With High IgE Levels

Omalizumab — an antibody against immunoglobulin E (IgE) — may be effective and safe for wound healing in patients with recessive dystrophic epidermolysis bullosa (RDEB) and high IgE levels, a small study suggests. The treatment was also safe and well-tolerated, suggesting it may provide a therapeutic alternative for a disease with no “consistently effective” therapies, the scientists wrote. The study, “The clinical efficacy and safety of anti-IgE therapy in recessive dystrophic epidermolysis bullosa,” was published in…

You must be logged in to read/download the full post.